Literature DB >> 21211640

Health economics of allergen-specific immunotherapy in the United States.

Richard F Lockey, Cheryl S Hankin.   

Abstract

Mesh：

Year:  2011        PMID： 21211640     DOI： 10.1016/j.jaci.2010.09.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

Authors:  Ravi K Viswanathan; William W Busse
Journal:  Chest       Date:  2012-05       Impact factor: 9.410

2.  Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.

Authors:  Joshua L Kennedy; Derek Robinson; Jared Christophel; Larry Borish; Spencer Payne
Journal:  Am J Rhinol Allergy       Date:  2014 Jan-Feb       Impact factor: 2.467

3.  Allergen Immunotherapy: New Insights into an Old Treatment.

Authors:  Constantinos Pitsios
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

Review 4.  New directions in immunotherapy.

Authors:  Linda Cox; Enrico Compalati; Thomas Kundig; Mark Larche
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.